To further explore the clinical significance of GALNT2 in glioma, immunohistochemical staining was employed to characterize the in vivo expression of GALNT2 in different grades of clinical glioma specimens, and GALNT2 was found to be overexpressed in GBM than gliomas (Figure 1J, 1K). This evidence concerns the gene GALNT2 and glioblastoma.